IP Library › Granted Patent US 8,946,505
Granted Patent B2
US 8,946,505 · App. 13/934,829 · Granted Feb 3, 2015

Promoter-regulated differentiation-dependent self-deleting cassette

Inventors: David Frendewey (New York, NY); Guochun Gong (Elmsford, NY); Ka-Man Venus Lai (Tarrytown, NY); David M. Valenzuela (Yorktown Heights, NY)
Assignee: Regeneron Pharmaceuticals, Inc.
C12N15/873A01K67/0275C12N15/8509C12N15/907C12N15/85A01K2217/07A01K2217/206A01K2227/105C12N2800/30C12N2840/102
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,946,505
App. No.
13/934,829
Granted
Feb 3, 2015
Kind
B2
Abstract

Targeting constructs and methods of using them are provided for differentiation-dependent modification of nucleic acid sequences in cells and in non-human animals. Targeting constructs comprising a promoter operably linked to a recombinase are provided, wherein the promoter drives transcription of the recombinase in an differentiated cell but not an undifferentiated cell. Promoters include Blimp1, Prm1, Gata6, Gata4, Igf2, Lhx2, Lhx5, and Pax3. Targeting constructs with a cassette flanked on both sides by recombinase sites can be removed using a recombinase gene operably linked to a 3′-UTR that comprises a recognition site for an miRNA that is transcribed in undifferentiated cells but not in differentiated cells. The constructs may be included in targeting vectors, and can be used to automatically modify or excise a selection cassette from an ES cell, a non-human embryo, or a non-human animal.

Claims (23)

1. A method for making a genetically modified F0 mouse, comprising:

(a) introducing a donor mouse ES cell into a host mouse embryo, wherein the donor mouse ES cell is genetically modified to comprise:

(i) a selection cassette that comprises a selectable marker, wherein the selection cassette is flanked upstream and downstream with recombinase recognition sites, and

(ii) a recombinase expression cassette that comprises a recombinase gene operably linked to a Blimp1 promoter, wherein the Blimp1 promoter has the sequence comprising SEQ ID NO:2 or SEQ ID NO:3, and wherein the recombinase expression cassette is flanked upstream and downstream with the recombinase recognition sites;

(b) implanting the host mouse embryo of step (a) into a mouse capable of gestating the host mouse embryo;

(c) maintaining the mouse of step (b) under conditions sufficient for gestation; and,

(d) obtaining from the mouse of step (c) a genetically modified F0 mouse that lacks a selection cassette and the recombinase expression cassette in a germ cell and retains a selection cassette and the recombinase expression cassette in a non-germ cell.

2. The method of claim 1 , wherein the genetically modified mouse is a male and lacks the selection cassette and the recombinase expression cassette in its germ cells.

3. The method of claim 1 , wherein the selectable marker is operably linked to a promoter that is not a Blimp1 promoter.

4. The method of claim 3 , wherein the selectable marker is operably linked to a promoter selected from the group consisting of a UbC promoter, an hCMV promoter, an mCMV promoter, a CAGGS promoter, an EF1 promoter, a Pgk1 promoter, a beta-actin promoter, and a ROSA26 promoter.

5. The method of claim 3 , wherein the selectable marker is a neomycin phosphotransferase (neo r ) gene and is operably linked to a UbC promoter.

6. The method of claim 2 , further comprising: (e) breeding the genetically modified mouse to a female mouse, wherein the breeding results in progeny that lack the selection cassette and the recombinase expression cassette.

7. An F0 mouse made by a method comprising:

(a) introducing a donor mouse ES cell into a host mouse embryo, wherein the donor mouse ES cell is genetically modified to comprise:

(i) a selection cassette that comprises a selectable marker, wherein the selection cassette is flanked upstream and downstream with recombinase recognition sites, and

(ii) a recombinase expression cassette that comprises a recombinase gene operably linked to a Blimp1 promoter, wherein the Blimp1 promoter has the set sequence comprising SEQ ID NO:2 or SEQ ID NO:3, and wherein the recombinase expression cassette is flanked upstream and downstream with the recombinase recognition sites;

(b) implanting the host mouse embryo of step (a) into a mouse capable of gestating the host mouse embryo;

(c) maintaining the host mouse of step (b) under conditions sufficient for gestation; and,

(d) obtaining from the mouse of step (c) a genetically modified F0 mouse that lacks a selection cassette and the recombinase expression cassette in a germ cell and retains a selection cassette and the recombinase expression cassette in a non-germ cell.

8. The mouse of claim 7 , wherein the genetically modified mouse is a male and lacks the selection cassette and the recombinase expression cassette in its germ cells.

9. The mouse of claim 7 , wherein the selectable marker is operably linked to a promoter that is not a Blimp1 promoter.

10. The mouse of claim 9 , wherein the selectable marker is operably linked to a promoter selected from the group consisting of a UbC promoter, an hCMV promoter, an mCMV promoter, a CAGGS promoter, an EF 1 promoter, a Pgk1 promoter, a beta-actin promoter, and a ROSA26 promoter.

11. The mouse of claim 9 , wherein the selectable marker is a neomycin phosphotransferase (neo r ) gene and is operably linked to a UbC promoter.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 16, 2013
From: FRENDEWEY, DAVID; GONG, GUOCHUN; LAI, KA-MAN VENUS; VALENZUELA, DAVID M.
To: REGENERON PHARMACEUTICALS, INC.
Reel/Frame 031414/0248 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2013
From: FRENDEWEY, DAVID; GONG, GUOCHUN; LAI, KA-MAN VENUS; VALENZUELA, DAVID M.
To: REGENERON PHARMACEUTICALS, INC.
Reel/Frame 031308/0352 →
Continuity (3)
Division 12856163 · Aug 13, 2010
Provisional Application 61233974 · Aug 14, 2009
Related Publication 20130312129A1 · Nov 21, 2013